| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |